BHT-3009

· Bayhill Therapeutics

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BHT-3009, covering 2008-02-11 to 2008-04-07. Get the full timeline:

Most recent: Clinical Trial Update: Immunotherapy With BHT-3009 Alone or Combined With Atorvastatin in Patients With Multiple Sclerosis [Phase 1]